# Immune Response of Healthy Subjects Who Received Neonatal Vaccination Course With Engerix™-B Vaccine.

> **NCT00774995** · PHASE4 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 49 (actual)

## Conditions studied

- Hepatitis B

## Interventions

- **BIOLOGICAL:** EngerixTM-B

## Key facts

- **NCT ID:** NCT00774995
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-11
- **Primary completion:** 2010-06
- **Final completion:** 2010-06
- **Target enrollment:** 49 (ACTUAL)
- **Last updated:** 2016-11-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00774995

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00774995, "Immune Response of Healthy Subjects Who Received Neonatal Vaccination Course With Engerix™-B Vaccine.". Retrieved via AI Analytics 2026-08-18 from https://api.ai-analytics.org/clinical/NCT00774995. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*